FOREX.com by StoneX logo

Gold Loses Shine on Moderating Coronavirus Fears

Spot gold posted the largest decline in nearly two weeks yesterday, amid growing signs of easing coronavirus pandemic...

Global Author
Global Author

Share this:

Gold Loses Shine on Moderating Coronavirus Fears

Spot gold dropped 1.6% to $1,686.5 yesterday, the largest decline in nearly two weeks. Despite gloomy GDP data from the Eurozone and the U.S., the coronavirus crisis appears to be moderating. Following other European countries, U.K. Prime Minster Boris Johnson said he will propose plans to unlock the economy in the coming weeks and declared that his country has passed the coronavirus peak. 

In the U.S., the number of new coronavirus cases rose just 1.2% on Thursday, the smallest increase in April, according to Johns Hopkins University. Meanwhile, National Institute of Allergy and Infectious Diseases director Anthony Fauci said on a NBC interview he expects the Food and Drug Administration to approve remdesivir, a potential treatment to coronavirus patients, relatively soon.

Form a technical point of view, spot gold extended its bearish run as shown on the 1-hour chart. After a recent decline, it has broken below its previous trading range and has potentially formed a lower-high. Bearish investors might consider $1,700 as the nearest intraday resistance, with potential downside targets at $1,671 and $1,661. In an alternative scenario, a break above $1,700 may trigger a revisit to $1,709 and $1,722 on the upside.

Source: TradingView, Gain Capital


Spot gold dropped 1.6% to $1,686.5 yesterday, the largest decline in nearly two weeks. Despite gloomy GDP data from the Eurozone and the U.S., the coronavirus crisis appears to be moderating. Following other European countries, U.K. Prime Minster Boris Johnson said he will propose plans to unlock the economy in the coming weeks and declared that his country has passed the coronavirus peak. 

In the U.S., the number of new coronavirus cases rose just 1.2% on Thursday, the smallest increase in April, according to Johns Hopkins University. Meanwhile, National Institute of Allergy and Infectious Diseases director Anthony Fauci said on a NBC interview he expects the Food and Drug Administration to approve remdesivir, a potential treatment to coronavirus patients, relatively soon.

Form a technical point of view, spot gold extended its bearish run as shown on the 1-hour chart. After a recent decline, it has broken below its previous trading range and has potentially formed a lower-high. Bearish investors might consider $1,700 as the nearest intraday resistance, with potential downside targets at $1,671 and $1,661. In an alternative scenario, a break above $1,700 may trigger a revisit to $1,709 and $1,722 on the upside.

Source: TradingView, Gain Capital


Related tags:

The complete CFD trading experience

Award-winning platforms, competitive spreads, low commissions and dedicated support.

We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.

Economic calendar

Web Trader platform

Our sophisticated web-based platform is packed with features.

Related articles

Gold forecast: Rising yields become too hot for gold, but the outlook is far from bearish

Gold and silver prices took a plunge today, with the former down 3% and the latter falling some 5% by mid European session, before bouncing off their lows. The losses come after the metals remained largely supported until last week, despite the big dollar rally and surging bond yields as we have seen in recent weeks. But it simply got too much, and the metals succumbed to pressure today.

StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.

StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.

It's your world. Trade it.